Genetic characterization of CHO production host DG44 and derivative recombinant cell lines
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The dihydrofolate reductase-deficient Chinese hamster ovary (CHO) cell line DG44 is the dominant mammalian host for recombinant protein manufacturing, in large part because of the availability of a well-characterized genetic selection and amplification system. However, this cell line has not been studied at the cytogenetic level. Here, the first detailed karyotype analysis of DG44 and several recombinant derivative cell lines is described. In contrast to the 22 chromosomes in diploid Chinese hamster cells, DG44 has 20 chromosomes, only seven of which are normal. In addition, four Z group chromosomes, seven derivative chromosomes, and 2 marker chromosomes were identified. For all but one of the 16 DG44-derived recombinant cell lines analyzed, a single integration site was detected by fluorescence in situ hybridization regardless of the gene delivery method (calcium phosphate-DNA coprecipitation or microinjection), the topology of the DNA (circular or linear), or the integrated plasmid copy number (between 1 and 51). Chromosomal aberrations, observed in more than half of the cell lines studied, were mostly unbalanced with examples of aneuploidy, deletions, and complex rearrangements. The results demonstrate that chromosomal aberrations are frequently associated with the establishment of recombinant CHO DG44 cell lines. Noteworthy, there was no direct correlation between the stability of the genome and the stability of recombinant protein expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032
Self-citationKwaks, T. H. J., Barnett, P., Hemrika, W., Siersma, T., Sewalt, R. G. A. B., Satijn, D. P. E., Brons, J. F., van Blokland, R., Kwakman, P., Kruckeberg, A. L., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt814 · Cited by 126
Cited by
Lewis, N. E., Liu, X., Li, Y., Nagarajan, H., Yerganian, G., O'Brien, E., Bordbar, A., Roth, A. M., Rosenbloom, J., Bian, C., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2624 · Cited by 380
Advances in Mammalian cell line development technologies for recombinant protein production
Lai, T., Yang, Y., & Ng, S. (2013) · Pharmaceuticals · doi:10.3390/ph6050579 · Cited by 322
“established [23].”
The art of CHO cell engineering: A comprehensive retrospect and future perspectives
Fischer, S., Handrick, R., & Otte, K. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.10.015 · Cited by 312
Chinese hamster genome sequenced from sorted chromosomes
Brinkrolf, K., Rupp, O., Laux, H., Kollin, F., Ernst, W., Linke, B., Kofler, R., Romand, S., Hesse, F., Budach, W. E., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2645 · Cited by 166
Feichtinger, J., Hernández, I., Fischer, C., Hanscho, M., Auer, N., Hackl, M., Jadhav, V., Baumann, M., Krempl, P. M., Schmidl, C., et al. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.25990 · Cited by 148
“The highest degree of variation occurs with SVs, most prominently with translocations, confirming previous reports of chromosomal rearrangements and irregularities in numbers (Cao et al., 2012; Derouazi et al., 2006).”
BackgroundReflections on more than 10 years of TGE approaches
Geisse, S. (2009) · Protein Expression and Purification · doi:10.1016/j.pep.2008.10.017 · Cited by 117
Transient and stable vector transfection: Pitfalls, off-target effects, artifacts
Stepanenko, A. A., & Heng, H. H. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2017.05.002 · Cited by 109
Stolfa, G., Smonskey, M. T., Boniface, R., Hachmann, A., Gulde, P., Joshi, A. D., Pierce, A. P., Jacobia, S. J., & Campbell, A. (2018) · Biotechnology Journal · doi:10.1002/biot.201700227 · Cited by 97
High-level transgene expression by homologous recombination-mediated gene transfer
Grandjean, M., Girod, P.-A., Calabrese, D., Kostyrko, K., Wicht, M., Yerly, F., Mazza, C., Beckmann, J. S., Martinet, D., & Mermod, N. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr436 · Cited by 53
“As the CHO DG44 are near-diploid cells (55), we estimated that 176 copies of the GAPDH genes and pseudogenes occur in the genome of CHO DG44 cells.”
Self-citationE2F-1 overexpression increases viable cell density in batch cultures of Chinese hamster ovary cells
Majors, B. S., Arden, N., Oyler, G. A., Chiang, G. G., Pederson, N. E., & Betenbaugh, M. J. (2008) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2008.08.003 · Cited by 36
“, 2007), or significant chromosomal aberrations such as aneuploidy and complex rearrangements (Derouazi et al., 2006) known for these transformed cells.”
BackgroundCombs, R. G., Yu, E., Roe, S., Piatchek, M. B., Jones, H. L., Mott, J., Kennard, M. L., Goosney, D. L., & Monteith, D. (2011) · Biotechnology Progress · doi:10.1002/btpr.505 · Cited by 8
Metadata
- Authors
- Derouazi, M., Martinet, D., Besuchet Schmutz, N., Flaction, R., Wicht, M., Bertschinger, M., Hacker, D. L., Beckmann, J. S., & Wurm, F. M.
- Venue
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 340
- Issue
- 4
- Pages
- 1069-1077
- ISSN
- 0006-291X (ISSN-L)
- OpenAlex
- W2033032210
- Cited by
- 152
- References
- 2
- FWCI
- 1.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.